Quercetin attenuates the progression of chronic rhinosinusitis with nasal polyps by regulating macrophage M2 polarization and remodeling of nasal mucosa
Authors:
- 21 June 2025
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 162, 115120
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Administration of Hospitals (PZ2024006)
This publication has 37 references indexed in Scilit:
- Quercetin Alleviates the Progression of Chronic Rhinosinusitis Without Nasal Polyps by Inhibiting Nasal Mucosal Inflammation and Epithelial ApoptosisMolecular Biotechnology, 2024
- Macrophages in CRSwNP: Do they deserve more attention?International Immunopharmacology, 2024
- Pathogenesis of chronic rhinosinusitis with nasal polyp and a prominent T2 endotypeHeliyon, 2023
- Inhibition of IL-4/STAT6/IRF4 signaling reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polypsInternational Immunopharmacology, 2023
- Overexpression of AXL on macrophages associates with disease severity and recurrence in chronic rhinosinusitis with nasal polypsInternational Immunopharmacology, 2023
- Loss of SENP3 mediated the formation of nasal polyps in nasal mucosal inflammation by increasing alternative activated macrophageImmunity, Inflammation and Disease, 2023
- Quercetin inhibits the amphiregulin/EGFR signaling‐mediated renal tubular epithelial‐mesenchymal transition and renal fibrosis in obstructive nephropathyPhytotherapy Research, 2022
- Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPsClinical and Translational Allergy, 2021
- Hemokinin‐1 stimulates C‐C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polypsInternational Forum of Allergy & Rhinology, 2019
- Deficiency in interleukin‐10 production by M2 macrophages in eosinophilic chronic rhinosinusitis with nasal polypsInternational Forum of Allergy & Rhinology, 2018